MARIYANTHIE LINARIS: Open Payments
NPI 1063008498 · GARDEN CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,163 in 59 payments from 10 companies in 2025. Trend: 2023 $142 · 2024 $2,162 · 2025 $2,163
Food & beverage: $2,163
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $1,082 |
| Phathom Pharmaceuticals, Inc. | 5 | $246 |
| GENZYME CORPORATION | 4 | $207 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $180 |
| Regeneron Healthcare Solutions, Inc. | 4 | $164 |
| Lilly USA, LLC | 1 | $125 |
| Novo Nordisk Inc | 1 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $18 |
| Enterra Medical, Inc. | 1 | $17 |
Products named: RINVOQ, DUPIXENT, SKYRIZI, VOQUEZNA, XIFAXAN, OMVOH, Wegovy, CREON.
Industry payments across NY — which companies pay providers there.
